VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Anika Therapeutics, Inc. (ANIK) Total Return Calculator with Dividends Reinvested

Anika Therapeutics, Inc.

Popular:

The total return for Anika Therapeutics, Inc. (ANIK) stock is +7.39% over the past 12 months. So far it's up 61.71% this year. The 5-year total return is -62.92%, meaning $10,000 invested in ANIK stock 5 years ago would be worth $3,708 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ANIK 1 year ago, it would be worth $10,435 today — you'd have gained $435.

With Dividends Reinvested$10,435+4.35%

Price Only (No DRIP)$10,435+4.35%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ANIK

1Y$10,739+$739 (+7.4%)7.4% CAGR

3Y$5,820-$4,180 (-41.8%)-16.5% CAGR

5Y$3,708-$6,292 (-62.9%)-18.0% CAGR

10Y$3,434-$6,566 (-65.7%)-10.1% CAGR

15Y$20,712+$10,712 (+107.1%)5.0% CAGR

20Y$13,205+$3,205 (+32.1%)1.4% CAGR

30Y$28,130+$18,130 (+181.3%)3.5% CAGR

Anika Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading ANIK total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+61.71%	—	+61.71%	—	$16,171
1Y	+7.39%	7.39%	+7.39%	—	$10,739
3Y	-41.80%	-16.51%	-41.80%	—	$5,820
5Y	-62.92%	-18.00%	-62.92%	—	$3,708
10Y	-65.66%	-10.14%	-65.66%	—	$3,434
15Y	+107.12%	4.97%	+107.12%	—	$20,712
20Y	+32.05%	1.40%	+32.05%	—	$13,205
30Y	+181.30%	3.51%	+181.30%	—	$28,130

Risk & Highlights

Best Year+836.54%2003

Worst Year-88.84%2000

Max Drawdown-45.45%2025-05-08 → 2025-07-30 · Recovered 2026-03-09

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+53.58%	+53.58%	—	+0.41%	+53.2pp
2025	-40.72%	-40.72%	—	+16.64%	-57.4pp
2024	-27.36%	-27.36%	—	+24.00%	-51.4pp
2023	-23.13%	-23.13%	—	+24.81%	-47.9pp
2022	-18.99%	-18.99%	—	-19.95%	+1.0pp

ANIK underperformed the S&P 500 by 23.94pp over the past year (+7.39% vs +31.32%).

Loading summary...

ANIK Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ANIKAnika Therapeutics, Inc.	$203M	+2.5%	+61.7%	+7.4%	—	-41.8%	-62.9%	-65.7%
MDXGMiMedx Group, Inc.	$544M	-5.7%	-43.5%	-44.6%	—	-37.1%	-62.3%	-48.4%
NVCRNovoCure Limited	$1.9B	+56.4%	+25.7%	+1.0%	—	-76.2%	-91.5%	+31.0%
OSUROraSure Technologies, Inc.	$216M	-2.6%	+26.1%	+7.1%	—	-57.1%	-69.2%	-54.8%
ATRCAtriCure, Inc.	$1.4B	-4.0%	-28.7%	-6.2%	—	-41.4%	-64.0%	+100.6%
LNTHLantheus Holdings, Inc.	$5.6B	+13.5%	+28.1%	-17.8%	—	-9.1%	+290.0%	+4002.4%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
ALGNAlign Technology, Inc.	$12.5B	+1.2%	+11.5%	+0.5%	—	-43.2%	-70.3%	+132.9%
GMEDGlobus Medical, Inc.	$12.1B	+0.7%	+2.2%	+26.7%	—	+53.4%	+22.4%	+289.8%
PRGOPerrigo Company plc	$1.7B	+15.8%	-9.6%	-45.6%	+4.7pp	-56.6%	-58.6%	-76.8%
OFIXOrthofix Medical Inc.	$489M	+3.6%	-17.9%	+1.1%	—	-34.5%	-72.2%	-71.6%

Compare:ANIK vs MDXG ANIK vs NVCR ANIK vs OSUR ANIK vs MDXG vs NVCR

About ANIK Dividend Returns

Anika Therapeutics, Inc. (ANIK) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ANIK over the past year?

Anika Therapeutics, Inc. (ANIK) delivered a return of 7.39% over the past year. Since ANIK does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ANIK be worth today?

A $10,000 investment in Anika Therapeutics, Inc. one year ago would be worth $10,739 today, representing a gain of $739.

Q3Does ANIK pay dividends?

Anika Therapeutics, Inc. (ANIK) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ANIK, the total return equals the price-only return.

Q4Did ANIK beat the S&P 500?

No, Anika Therapeutics, Inc. (ANIK) underperformed the S&P 500 by 23.94 percentage points over the past year. ANIK delivered a total return of 7.39%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed ANIK by 23.94pp during this period.

Q5What is ANIK's worst drawdown?

Anika Therapeutics, Inc. (ANIK) experienced a maximum drawdown of -45.45% over the past year, declining from its peak on 2025-05-08 to its trough on 2025-07-30. The stock recovered to its prior peak by 2026-03-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ANIK's long-term total return over 10, 20, or 30 years?

Here are Anika Therapeutics, Inc. (ANIK)'s long-term returns with dividends reinvested. Over 10 years, the total return is -65.7% (-10.1% CAGR) — $10,000 would have grown to $3,434. Over 20 years: 32.1% total return (1.4% CAGR) — $10,000 → $13,205. Over 30 years: 181.3% total return (3.5% CAGR) — $10,000 → $28,130. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ANIK's best and worst year?

Anika Therapeutics, Inc.'s best calendar year was 2003 with a total return of 836.5%. Its worst year was 2000 with a total return of -88.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 925.4 percentage points.